Liora, a subsidiary of LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), Introduces New CEO, Brings Experience to Treating Tumors with Proton Therapy
There are several types of technologies for treating tumors with proton therapy, such as pencil beam scanning, passive scattering, and…